(Q64188329)
Statements
A Phase 3, 12-Week, Multicenter, Randomized, Double-blind, Placebo-controlled, 2-Arm, Fixed-dose Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type (English)
0 references
16 May 2018
0 references
November 2020
0 references
225
0 references
55 year
0 references
90 year
0 references